Omicron estimated to be 2.9% of COVID-19 variants in U.S.
[ad_1]

(Reuters) – According to U.S. Centers for Disease Control and Prevention data, the Omicron variant represented 2.9% in total COVID-19 variants circulating across the United States at Dec. 11.
Omicron variant was 0.4% of all the variants in the country for week ending December 4, based upon the sequenced specimens.
According to the agency, the rapidly-spreading COVID-19 variant was also detected in South Africa and Botswana in November. It was estimated that 13.1% of all circulating COVID-19 variants were in New Jersey, New York and Puerto Rico for the week ended Dec. 11.
On Sunday, the World Health Organization stated that Omicron was less severe in South Africa than Delta. But, there are still questions about how much Omicron might be more virulent.
Are SGTF (Sequence Genome Target Failure) or S-gene Drop-out samples being prioritised for sequencing? Scott Gottlieb, former FDA Commissioner, stated on Twitter (NYSE :).
It is difficult to determine true prevalence estimates from the percentages if that’s true. Results must be viewed in context. Despite Omicron incidence rising rapidly, it is not clear that sequence breakdown represents true prevalence.
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this website’s data including quotes, charts, or buy/sell signal information. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.
[ad_2]
